| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 07/06/2004 | US6759409 Inhibitors of papilloma virus |
| 07/06/2004 | US6759065 Extraction method, pharmaceutical composition and a cosmetic composition |
| 07/01/2004 | WO2004013093A3 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 07/01/2004 | WO2004012656A3 Thiophene and furan derivatives as prostaglandin agonists and use thereof |
| 07/01/2004 | WO2003080577A3 Amidoacetonitrile compounds |
| 07/01/2004 | US20040127713 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs |
| 07/01/2004 | US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 07/01/2004 | US20040127498 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 07/01/2004 | US20040127482 Substituted heterocycle fused gamma-carbolines |
| 07/01/2004 | US20040127429 glycolipid ligand for natural killer T (NKT) cells; synthetic analogs of alpha -C-galactosylceramides |
| 06/30/2004 | EP1433781A1 Pyrrolidine carboxylic acid derivatives |
| 06/30/2004 | EP1432696A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 06/30/2004 | CN1509277A Process for preparing paclitaxel |
| 06/30/2004 | CN1508129A Method for synthesizing pyrrole amides |
| 06/29/2004 | US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic |
| 06/24/2004 | US20040122055 C10 carbonate taxane compositions |
| 06/24/2004 | DE20220885U1 Kristallines und amorphes Mupirocin-Calcium Crystalline and amorphous mupirocin calcium |
| 06/23/2004 | EP1429750A2 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 06/23/2004 | CN1506363A Photoactive dicyclic alcohol and its prepn, medicinal composition and use |
| 06/23/2004 | CN1506358A Benzofuran derivative and its prepn and use |
| 06/23/2004 | CN1154642C Pyranone compounds useful to treat retroviral infections |
| 06/17/2004 | WO2004050890A1 Process for producing macrolide compound |
| 06/17/2004 | WO2004050612A1 S-substituted n-1-[(hetero)aryl]alkyl-n′-[(hetero)aryl] alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1-[(hetero)aryl]alkyl-n′-[(hetero)aryl]alkylysothiocarbamides, a pharmaceutical compound and curing method |
| 06/17/2004 | WO2004050610A2 Modulators of melanocortin receptor |
| 06/17/2004 | WO2004050609A1 Substituted ureas and carbamates |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116417 Thiohydantoins and use thereof for treating diabetes |
| 06/17/2004 | US20040116388 triazine compoound inhibitors of enzymes that catalyze phosphoryl transfer and/or that bind ATP/GTP nucleotides |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | CA2508914A1 Modulators of melanocortin receptor |
| 06/17/2004 | CA2508783A1 S-substituted n-1-¬(hetero) aryl|alkyl-n'-¬(hetero)aryl|alkylisothiocarbamides, a method for the preparation of these, physiologically active s-substituted n-1-¬(hetero)aryl|alkyl-n'-¬(hetero)aryl|alkylisothiocarbamides, a pharmaceutical composition and method of treatment |
| 06/17/2004 | CA2507641A1 Method of producing macrolide compound |
| 06/17/2004 | CA2507484A1 Substituted ureas and carbamates |
| 06/16/2004 | EP1427717A1 Bioprecursors for percutaneous application |
| 06/16/2004 | EP1427408A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE) |
| 06/16/2004 | EP1248778B1 Substituted photochromic 2h-naphtho 1,2-b] pyran compounds |
| 06/16/2004 | CN1505635A Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides |
| 06/16/2004 | CN1505624A Piperazino-derivatives and their use as pde4 inhibitor |
| 06/16/2004 | CN1505503A Method for preparing submicron particle suspensions |
| 06/15/2004 | US6750248 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 06/15/2004 | US6750246 C-4 carbonate taxanes |
| 06/15/2004 | US6750245 C7 carbamate substituted taxanes |
| 06/15/2004 | US6750242 Positive modulators of nicotinic receptor agonists |
| 06/15/2004 | US6750233 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/10/2004 | US20040110805 Sulfur compounds such as 4-[(4-{3-[(2-adamantylamino)sulfonyl]propoxy}phenyl)sulfonyl]- N-hydroxytetrahydro-2H-pyran-4-carboximide, used as antagonists for metalloenzyme and/or aggrecanase activity; tissue repair |
| 06/10/2004 | US20040110768 (S)-3-(1H-indol-3-yl)-N-(1-methoxymethyl-cyclohexylmethyl)-2-methyl-2-[4-(4-nitro-phenyl)-oxazol-2-ylamino]-propionamide for example; cancer, psychological disorders, sexual disorders, eating disorders, inflammatory bowel disease, sleep disorders |
| 06/10/2004 | US20040110744 1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 06/09/2004 | EP1426378A1 2-benzoylchromone derivatives |
| 06/09/2004 | DE10256174A1 2-Benzoylchromonderivate 2-Benzoylchromonderivate |
| 06/09/2004 | CN1152860C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 06/08/2004 | US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals |
| 06/03/2004 | WO2004046121A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 06/03/2004 | WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 06/03/2004 | WO2004033448A3 Isolation, purification and synthesis of procyanidin b2 and uses thereof |
| 06/03/2004 | US20040106676 Water-soluble etoposide analogs and methods of use thereof |
| 06/03/2004 | US20040106606 Dihydropyrones with tethered heterocycles |
| 06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
| 06/02/2004 | EP1423385A1 Intermediates for preparing neuraminidase inhibitor conjugates |
| 06/02/2004 | EP1423376A1 Bicyclic compound, production and use thereof |
| 06/02/2004 | EP1423108A1 C-2' methylated derivatives of paclitaxel for use as antitumour agents |
| 06/02/2004 | EP0828500B1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 05/27/2004 | WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | US20040102639 Preparation of isocoumarin derivatives and intermediates for the synthesis thereof |
| 05/27/2004 | US20040102500 Peroxisome proliferator activated receptor alpha agonists |
| 05/27/2004 | US20040102479 Novel benzopyran or thiobenzopyran derivatives |
| 05/27/2004 | US20040102386 Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto |
| 05/27/2004 | CA2504737A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/26/2004 | EP1422218A1 Antiviral agent |
| 05/26/2004 | EP1339703B1 A process for the preparation of paclitaxel |
| 05/26/2004 | EP1137645B1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 05/26/2004 | CN1500081A Thiohydantonins and use thereof for treating diabetes |
| 05/25/2004 | US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
| 05/21/2004 | WO2004041812A1 Therapeutic compounds and methods |
| 05/21/2004 | WO2004041805A1 NEW PROCESS FOR THE PREPARATION OF RACEMIC ([2S[2R*[R[R*]]]] and ([2R[2S*[S[S*]]]]-(±)- α,α' -[imino-bis(methylene)]bis[6-fluorochroman-2-methanol] AND ITS PURE [2S[2R*[R[R*]& |
| 05/21/2004 | WO2004041201A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 05/21/2004 | WO2004004629A3 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 05/21/2004 | CA2504999A1 Therapeutic compounds and methods |
| 05/21/2004 | CA2504344A1 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 05/20/2004 | US20040097594 Sulfonamide inhibitors of aspartyl protease |
| 05/20/2004 | US20040097580 For therapy and prophylaxis of diseases or disorders induced by promotion of lipid peroxidation or accumulation of oxidized products |
| 05/20/2004 | US20040097579 Taxane formulations |
| 05/20/2004 | US20040097570 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097471 For therapy and prophylaxis of influenza infection |
| 05/19/2004 | EP1419152A1 Hiv inhibiting pyrimidines derivatives |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
| 05/19/2004 | CN1150178C Sidechain-bearing taxanes |
| 05/18/2004 | US6737239 Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |
| 05/12/2004 | EP1417211A2 Natural phospholipids of marine origin containing flavonoids and polyunsaturated phospholipids and their uses |
| 05/12/2004 | EP1417196A1 Dna-pk inhibitors |
| 05/12/2004 | EP1063235B1 Benzofurylpyrone derivatives |
| 05/12/2004 | CN1496362A Non-imidazole compounds as histamine H3 antagonists |
| 05/12/2004 | CN1495177A C-10 position paclitaxane derivative and its medicine composition |
| 05/12/2004 | CN1149210C Thrombin inhibitors |